New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
C21 Investments Inc.
CXXIF
Shape
US Flag

PNK

Unprofitable

Unprofitable

28M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Dec 2024

28M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Dec 2024

0.23USD
Shape0.01 ( 4.41%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

51%

Quote Panel

Shape
Updated October 16, 2024
1W 2.45 % 1M -1.36 % 3M -14.15 % 1Y -27.56 %

Key Metrics

Shape
  • Market Cap

    27.83M


  • Shares Outstanding

    120.05M


  • Share in Float

    97.13M


  • Dividende

    0


  • Earning Date

    12 Dec 2024


  • Price Target

    0.2318


  • Average Volume

    102176


  • Beta

    2.301


  • Range

    0.201-0.471


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cxxi.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.98x

P/S Ratio

0.86x

P/B Ratio

0.1

Debt/Equity

-15.6%

Net Margin

$-0.0

EPS

How CXXIF compares to sector?

P/E Ratio

Relative Strength

Shape

CXXIF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$87M

Shape1214%

2025-Revenue

$433K

Shape305%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+124%

0.01
vs -0.06

Q2.22

arrow
arrow

-79%

0.01
vs 0.04

Q3.22

arrow
arrow

-50%

0.02
vs 0.03

Q4.22

arrow
arrow

-93%

0
vs 0.03

Q1.23

arrow
arrow

N/A

-0.01
vs 0.01

Q2.23

arrow
arrow

N/A

-0.00
vs 0.01

Q3.23

arrow
arrow

N/A

-0.00
vs 0.02

Q4.23

arrow
arrow

N/A

-0.00
vs 0

Q1.24

arrow
arrow

N/A

-0.02
vs -0.01

Q2.24

arrow
arrow

N/A

-0.01
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-20%

7.2M  vs 9M

Q4.22

arrow
arrow

-12%

7.2M  vs 8.2M

Q1.23

arrow
arrow

+5%

7M  vs 6.7M

Q2.23

arrow
arrow

+3%

7.7M  vs 7.5M

Q3.23

arrow
arrow

0%

7.2M  vs 7.2M

Q4.23

arrow
arrow

-5%

6.9M  vs 7.2M

Q1.24

arrow
arrow

-6%

6.6M  vs 7M

Q2.24

arrow
arrow

-14%

6.6M  vs 7.7M

Q3.24

arrow
arrow

+100%

14.3M  vs 7.2M

Q4.24

arrow
arrow

+134%

16.1M  vs 6.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.03

Q4.22

arrow
arrow

+1%

0.01
vs 0.05

Q1.23

arrow
arrow

-4%

-0.04
vs 0.01

Q2.23

arrow
arrow

-1%

-0.01
vs -0.04

Q3.23

arrow
arrow

-1%

-0.01
vs -0.01

Q4.23

arrow
arrow

-1%

-0.01
vs -0.01

Q1.24

arrow
arrow

-7%

-0.07
vs -0.01

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Institutionnal OwnershipShape

status-upQoQ

Q4.19

arrow
arrow

1

1
vs NA

NA

Q1.20

arrow
arrow

1

1
vs 1

NA

Q3.21

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News